Skip to main content

Table 2 Univariate analysis of the association between prognostic variables and overall survival in NSCLC

From: Tumor-associated macrophage, angiogenesis and lymphangiogenesis markers predict prognosis of non-small cell lung cancer patients

Variables Hazard ratio (95% CI) p value
Age 1.01 (0.99–1.04) 0.267
Tumor grade 1.22 (0.93–1.60) 0.146
pT stage 3.57 (2.21–5.76)  < 0.001
pN stage 2.59 (1.72–3.91)  < 0.001
CD68high 0.62 (0.41–0.94) 0.024
CD163high 0.89 (0.60–1.35) 0.594
VEGF-Ahigh 0.68 (0.45–1.03) 0.071
VEGF-Chigh 1.14 (0.76–1.71) 0.531
M2 ratiohigh 1.61 (1.07–2.44) 0.024
Dual M2 ratiohigh & VEGF-Ahigh 1.23 (0.74–2.02) 0.424
Dual M2 ratiohigh & VEGF-Chigh 1.82 (1.18–2.80) 0.007
  1. M2 ratio, CD163+/CD68+
  2. NSCLC non-small cell lung cancer, CI confidence interval, VEGF vascular endothelial growth factor